Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Antje Prasse, Simone Brogi et al.|Journal of Medicinal Chemistry|2021Cited by 55
A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting ProfilesBasem Battah, Sandra Gemma, Giulia Chemi et al.|Molecules|2019Cited by 54
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological EvaluationA. Prasanth Saraswati, Giuseppe Campiani, Nicola Relitti et al.|ACS Medicinal Chemistry Letters|2020Cited by 44
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, Giuseppe Campiani, A. Prasanth Saraswati et al.|European Journal of Medicinal Chemistry|2020Cited by 43
Screening and Phenotypical Characterization of <i>Schistosoma mansoni</i> Histone Deacetylase 8 (<i>Sm</i>HDAC8) Inhibitors as Multistage Antischistosomal AgentsFulvio Saccoccia, Giovina Ruberti, Margherita Brindisi et al.|ACS Infectious Diseases|2019Cited by 27